US Broker Ratings

AstraZeneca PLC (AZN)

⚠️ No article content returned.

..

AptarGroup, Inc. (ATR)

⚠️ No article content returned.

..

AbbVie Inc. (ABBV) Stock Analysis: Strong Buy Ratings and a Promising 7.75% Upside

AbbVie Inc. (NYSE: ABBV), a leading player in the healthcare sector, continues to capture investor attention with its robust product portfolio and a promising outlook. With a market capitalization of..

BioMarin Pharmaceutical Inc. (BMRN): Investor Outlook Reveals 46% Potential Upside

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a biotechnology powerhouse, is making waves in the healthcare sector with its focus on developing therapies for rare diseases. With a market capitalization of $11.6..

Fresenius Medical Care AG (FMS) Stock Analysis: Navigating Challenges with Resilient Dividends and Modest Upside

Fresenius Medical Care AG (NYSE: FMS), a major player in the healthcare sector, specializes in providing dialysis services and related products to individuals with renal diseases. Operating globally, the company..

Molina Healthcare Inc (MOH) Stock Analysis: Navigating a 6.90% Potential Upside Amidst Mixed Performance Metrics

Molina Healthcare Inc (NYSE: MOH), a prominent player in the healthcare plans industry, has been capturing investor attention due to its unique position in providing managed healthcare services to low-income..

Cardinal Health, Inc. (CAH) Stock Analysis: Evaluating a Healthcare Giant with a 9.72% Potential Upside

Cardinal Health, Inc. (NYSE: CAH), a leading player in the healthcare sector, presents a compelling case for investors seeking exposure to the medical distribution industry. With a market capitalization of..

GE HealthCare Technologies Inc. (GEHC) Stock Report: Strong Buy Ratings and 21% Potential Upside

GE HealthCare Technologies Inc. (NYSE: GEHC), a key player in the healthcare sector, is attracting investor attention with its promising growth metrics and strong analyst support. With a market capitalization..

HCA Healthcare, Inc. (HCA) Stock Analysis: Evaluating a Potential 12.62% Upside in the Healthcare Sector

In the ever-evolving landscape of healthcare, HCA Healthcare, Inc. (NYSE: HCA) stands as a formidable player. With a market capitalization of $89.31 billion, this Nashville-based giant operates an extensive network..

Takeda Pharmaceutical Company L (TAK): Investor Outlook Highlights 26.94% Potential Upside

Takeda Pharmaceutical Company Limited (NYSE: TAK), a leading player in the healthcare sector, stands out not just for its rich history dating back to 1781, but also for its robust..

Agilent Technologies, Inc. (A) Stock Analysis: Evaluating a 15% Potential Upside Amidst a Robust Revenue Growth

Agilent Technologies, Inc. (NYSE: A), a prominent player in the healthcare sector, operates within the diagnostics and research industry, offering a comprehensive range of solutions for life sciences, diagnostics, and..

DexCom, Inc. (DXCM) Stock Analysis: Strong Analyst Ratings and Promising 11.20% Potential Upside

DexCom, Inc. (NASDAQ: DXCM) continues to chart a promising trajectory in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $31.49 billion, DexCom has established..

Elevance Health, Inc. (ELV) Stock Analysis: Exploring a Potential 19.49% Upside in the Healthcare Sector

Elevance Health, Inc. (NYSE: ELV), a stalwart in the healthcare sector, presents a compelling investment case with a potential upside of 19.49%, according to analyst target prices. With its roots..

Eli Lilly and Company (LLY)

⚠️ No article content returned.

..

Quest Diagnostics (DGX) Stock Analysis: Exploring Growth Potential and Investor Sentiment

Investors have long regarded Quest Diagnostics Incorporated (NYSE: DGX) as a stalwart in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $25.72 billion,..

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: Strong Buy Ratings Propel Potential 9.3% Upside

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is making waves in the biotechnology sector, capturing investor attention with its innovative portfolio and promising financial metrics. With a robust market capitalization of $78.52..

Alcon Inc. (ALC) Stock Analysis: 26.66% Potential Upside in Healthcare Giant

Alcon Inc. (NYSE: ALC), a prominent player in the healthcare sector, particularly in the medical instruments and supplies industry, is drawing attention from investors with a compelling potential upside of..

Centene Corporation (CNC) Stock Analysis: Navigating Healthcare’s Complex Terrain with a 13.58% Upside

For investors eyeing the healthcare sector, Centene Corporation (NYSE: CNC) presents a compelling opportunity with a potential upside of 13.58%, according to analyst consensus. As a major player in the..

Baxter International Inc. (BAX) Stock Analysis: Navigating Healthcare Opportunities with a 4.33% Potential Upside

Baxter International Inc. (NYSE: BAX) stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $13.52 billion, the..

argenx SE (ARGX) Stock Analysis: Biotech Giant’s 26% Potential Upside and Robust Growth

argenx SE (NASDAQ: ARGX), a Netherlands-based biopharmaceutical powerhouse, continues to capture investor attention with its impressive market cap of $53.42 billion and a notable potential upside of 26.44%, as projected..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds